GlassScriptPhysician profile
Cassandra Waters Pike
NPI 1538113279
$1,051.38
in general payments reported to CMS, 2019-2025
19 companies · $99.47 in 2025
The $99.47 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $513 · 2020: $214 · 2021: $33.28 · 2022: $99.66 · 2023: $75.91 · 2024: $15.97 · 2025: $99.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $414.84 | 2019-2020 | |
| Smith+Nephew, INC. | $111.48 | 2019-2023 | Grafix Pl |
| Sebela Pharmaceuticals INC. | $97.18 | 2019-2023 | Naftin |
| Organogenesis INC. | $91.37 | 2019-2025 | Simplimax, Puraply |
| Stryker Corporation | $37.02 | 2023-2025 | Ortholoc 2 Lapifuse, Pro-Toe |
| Kerecis Limited | $34.62 | 2020-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Paratek Pharmaceuticals, INC. | $33.16 | 2022 | |
| Abbott Laboratories | $32.90 | 2020-2021 | |
| Melinta Therapeutics, LLC | $27.84 | 2019 | |
| Horizon Therapeutics Plc | $27.31 | 2019 | |
| Arthrosurface Incorporated | $27.18 | 2025 | Toe Motiontm |
| Globus Medical, INC. | $19.90 | 2025 | Senza |
| Nabriva Therapeutics, Plc | $17.70 | 2021 | |
| Biotissue Holdings INC. | $15.97 | 2024 | |
| Linvatec Corporation | $14.75 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $12.86 | 2020 | |
| Integra Lifesciences Corporation | $12.59 | 2020 | |
| Ethicon US, LLC | $11.40 | 2019 | |
| Hikma Pharmaceuticals USA | $11.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra Pike listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.